Healthcare Services Group HCSG
$24.72 −$0.05 (-0.20%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $24.72 0.00%
Open$24.72
Prev close$24.77
Day range$24.67 – $25.38
Volume551.9K
Market cap$1.67B
P/E (TTM)16.7
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$479.60M+3.3% YoY
Operating profit$31.26M-36.9% YoY
Net profit$24.88M-42.1% YoY
Diluted EPS$0.36-39.0% YoY
Free cash flow$28.10M-59.8% YoY
Operating cash flow$30.17M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin16.1%
Operating margin6.3%
Net margin5.6%
Return on equity20.4%
Return on assets12.7%
Return on invested capital20.1%
Current ratio2.82
Liabilities / assets37.5%
Cash & investments$168.82M
Total debt$11.43M
Net cash (debt)$157.39M
Free cash flow / sales5.7%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $479.60M | $470.81M | $462.77M | $1.84B | $466.68M |
| Total Operating Revenue | $479.60M | $470.81M | $462.77M | $1.84B | $466.68M |
| Cost of Revenue | $399.22M | $396.02M | $386.93M | $1.60B | $394.61M |
| Gross Profit | $80.39M | $74.79M | $75.83M | $239.41M | $72.07M |
| Operating Expense | $49.13M | $45.69M | $43.57M | $183.61M | $45.83M |
| Selling and Admin Expenses | $49.13M | $45.69M | $43.57M | $183.61M | $45.83M |
| Operating Profit | $31.26M | $29.10M | $32.27M | $55.80M | $26.24M |
| Net Non-Operating Interest Income (Expense) | -$318,000.00 | -$619,000.00 | -$365,000.00 | -$1.58M | -$374,000.00 |
| Non-Operating Interest Expense | $318,000.00 | $619,000.00 | $365,000.00 | $1.58M | $374,000.00 |
| Other Income (Expense) | $2.78M | $2.52M | $2.64M | $13.65M | $2.69M |
| Gain on Sale of Security | $2.78M | $2.52M | $2.64M | $13.65M | $2.69M |
| Pretax Profit | $33.73M | $31.00M | $34.54M | $67.87M | $28.55M |
| Tax | $8.85M | $8.31M | $8.48M | $8.81M | -$2.69M |
| Net Profit | $24.88M | $22.70M | $26.06M | $59.06M | $31.24M |
| Profit from Continuing Operations | $24.88M | $22.70M | $26.06M | $59.06M | $31.24M |
| Net Income to Parent Company | $24.88M | $22.70M | $26.06M | $59.06M | $31.24M |
| Net Income to Common Stockholders | $24.88M | $22.70M | $26.06M | $59.06M | $31.24M |
| Basic EPS | $0.37 | $0.33 | $0.37 | $0.82 | $0.44 |
| Diluted EPS | $0.36 | $0.32 | $0.37 | $0.81 | $0.44 |
| Dividend Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $850.40M | $820.86M | $814.85M | $794.25M | $794.25M |
| Total Current Assets | $582.76M | $568.53M | $601.23M | $576.42M | $576.42M |
| Cash and Cash Equivalents & Short-Term Investments | $168.82M | $164.72M | $178.61M | $167.96M | $167.96M |
| -Cash and Cash Equivalents | $134.60M | $123.41M | $136.17M | $125.19M | $125.19M |
| -Short Term Investments | $34.22M | $41.32M | $42.44M | $42.77M | $42.77M |
| Receivables | $334.10M | $324.13M | $342.74M | $334.79M | $334.79M |
| -Accounts Receivable | $309.60M | $292.79M | $299.44M | $281.30M | $281.30M |
| -Notes Receivable | $24.50M | $26.68M | $29.07M | $31.24M | $31.24M |
| -Taxes Receivable | $0.00 | $4.66M | $14.23M | $22.25M | $22.25M |
| Prepaid Assets | $12.32M | $14.04M | – | – | – |
| Inventory | $15.53M | $15.84M | $15.89M | $16.80M | $16.80M |
| Restricted Cash | $35.48M | $36.14M | $36.00M | $35.93M | $35.93M |
| Current Deferred Assets | $2.48M | $2.29M | – | – | – |
| Other Current Assets | $14.03M | $11.36M | $27.99M | $20.93M | $20.93M |
| Total Non-Current Assets | $267.64M | $252.33M | $213.62M | $217.84M | $217.84M |
| Net PPE | $30.78M | $29.92M | $27.03M | $27.59M | $27.59M |
| -Gross PPE | $62.63M | $61.34M | $59.29M | $59.83M | $59.83M |
| -Accumulated Depreciation | -$31.85M | -$31.42M | -$32.26M | -$32.25M | -$32.25M |
| Non-Current Note Receivables | $42.35M | $34.86M | $20.63M | $25.21M | $25.21M |
| Goodwill and Other Intangible Assets | $107.32M | $98.92M | $86.11M | $86.76M | $86.76M |
| -Goodwill | $90.46M | $85.80M | $79.80M | $79.80M | $79.80M |
| -Other Intangible Assets | $16.86M | $13.11M | $6.32M | $6.96M | $6.96M |
| Non-Current Deferred Assets | $77.66M | $79.06M | $70.96M | $74.38M | $74.38M |
| Other Non-Current Assets | $9.54M | $9.57M | $8.88M | $3.90M | $3.90M |
| Total Liabilities | $318.95M | $302.02M | $301.08M | $284.04M | $284.04M |
| Total Current Liabilities | $206.42M | $188.12M | $193.37M | $170.38M | $170.38M |
| Payables | $93.90M | $86.10M | $83.12M | $77.38M | $77.38M |
| -Accounts Payable | $92.17M | $86.10M | $83.12M | $77.38M | $77.38M |
| -Total Tax Payable | $1.73M | – | – | $0.00 | $0.00 |
| Current Accrued Expenses | $83.25M | $72.06M | $81.41M | $92.99M | $92.99M |
| Short-Term Debt and Capital Lease Obligation | $6.61M | $6.40M | $5.29M | – | – |
| -Current Capital Lease Obligation | $6.61M | $6.40M | $5.29M | – | – |
| Current Deferred Liabilities | $21.58M | $22.53M | $22.30M | – | – |
| Other Current Liabilities | $1.09M | $1.03M | $1.24M | – | – |
| Total Non-Current Liabilities | $112.53M | $113.90M | $107.71M | $113.67M | $113.67M |
| Non-Current Accrued Expenses | $41.16M | $42.62M | $43.82M | $46.14M | $46.14M |
| Long Term Debt and Capital Lease Obligation | $11.43M | $11.33M | $9.36M | $9.66M | $9.66M |
| -Long Term Capital Lease Obligation | $11.43M | $11.33M | $9.36M | $9.66M | $9.66M |
| Non-Current Deferred Liabilities | $59.12M | $59.14M | $52.93M | $56.28M | $56.28M |
| Other Non-Current Liabilities | $814,000.00 | $809,000.00 | $1.59M | $1.59M | $1.59M |
| Total Equity | $531.45M | $518.84M | $513.77M | $510.21M | $510.21M |
| Stockholders' Equity | $531.45M | $518.84M | $513.77M | $510.21M | $510.21M |
| Capital Stock | $773,000.00 | $773,000.00 | $773,000.00 | $768,000.00 | $768,000.00 |
| -Common Stock | $773,000.00 | $773,000.00 | $773,000.00 | $768,000.00 | $768,000.00 |
| Additional Paid-In Capital | $334.30M | $331.40M | $328.75M | $327.96M | $327.96M |
| Retained Earnings | $357.30M | $332.43M | $309.73M | $283.67M | $283.67M |
| Less: Treasury Stock | -$157.56M | -$144.82M | -$124.65M | -$101.73M | -$101.73M |
| Gains/Losses Not Affecting Retained Earnings | -$3.36M | -$938,000.00 | -$835,000.00 | -$448,000.00 | -$448,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $30.17M | $21.87M | $43.73M | $144.97M | $17.39M |
| Net cash flow from continuing operations | $30.17M | $21.87M | $43.73M | $144.97M | $17.39M |
| Net Income from Continuing Operations | $24.88M | $22.70M | $26.06M | $59.06M | $31.24M |
| Gain/Loss from Continuing Operations | $224,000.00 | $90,000.00 | $91,000.00 | $2.81M | $169,000.00 |
| Depreciation & Depletion & Amortization | $4.06M | $3.52M | $3.81M | $16.78M | $3.87M |
| Deferred Tax | $1.93M | -$1.93M | $607,000.00 | $19.20M | $3.26M |
| Change in Working Capital | -$823,000.00 | -$2.59M | $4.99M | -$40.55M | -$27.50M |
| -Change in Receivables | -$17.06M | -$9.28M | -$15.17M | $5.23M | -$28,000.00 |
| -Change in Inventory | $301,000.00 | $54,000.00 | $906,000.00 | -$48,000.00 | $405,000.00 |
| -Change in Prepaid Assets | -$1.08M | $104,000.00 | -$7.80M | $2.62M | $6.23M |
| -Change in Payables and Accrued Expense | -$7.24M | $7.48M | $20.60M | -$68.37M | -$58.81M |
| -Change In Other Working Capital | $23.45M | -$949,000.00 | $6.45M | $20.02M | $24.32M |
| Net cash flow from investing | -$7.22M | -$13.76M | -$11.55M | -$11.00M | $8.56M |
| Net Cash Flow from Continuing Investing Activities | -$7.22M | -$13.76M | -$11.55M | -$11.00M | $8.56M |
| Net PPE Purchase and Sale | -$2.05M | -$1.54M | -$1.34M | -$5.71M | -$1.36M |
| Net Business Purchase and Sale | -$10.06M | -$12.79M | $0.00 | -$7.15M | $134,000.00 |
| Net Investment Purchase and Sale | $4.90M | $581,000.00 | -$10.21M | $1.86M | $9.79M |
| Financing Cash Flow | -$11.70M | -$20.92M | -$26.68M | -$63.33M | -$19.60M |
| Net Cash Flow from Continuing Financing Activities | -$11.70M | -$20.92M | -$26.68M | -$63.33M | -$19.60M |
| Net Common Stock Issuance | -$11.74M | -$20.93M | -$23.96M | -$61.59M | -$19.60M |
| Proceeds from Stock Option Exercised | $38,000.00 | $4,000.00 | $1.45M | – | – |
| Net Other Financing Charges | $0.00 | $0.00 | -$4.16M | -$1.74M | $0.00 |
| Ending Cash Balance | $134.71M | $123.46M | $136.27M | $130.77M | $130.77M |
| Net Change in Cash | $11.25M | -$12.81M | $5.50M | $70.64M | $6.35M |
| Beginning Cash Balance | $123.46M | $136.27M | $130.77M | $60.13M | $124.42M |
| Free Cash Flow | $28.10M | $20.24M | $42.33M | $139.15M | $16.01M |
| -Change in Other Current Liabilities | – | – | $0.00 | – | – |
| Other Non-Cash Items | – | – | – | -$384,000.00 | – |
| Net Issuance Payments Of Debt | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on HCSG.
Sign in to join the discussion.